Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
// Hsin-Hwa Tsai 1, * , Hong-Yue Lai 2, * , Yueh-Chiu Chen 3, * , Chien-Feng Li 4 , Huei-Sheng Huang 5 , Hsiao-Sheng Liu 6 , Yau-Sheng Tsai 7 , Ju-Ming Wang 1, 8 1 Institute of Bioinformatics and Biosignal Transduction, National Cheng Kung University, Tainan, Taiwan 2 Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan 3 Department of Pharmacology, National Cheng Kung University, Tainan, Taiwan 4 Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan 5 Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan 6 Department of Microbiology and Immunology, National Cheng Kung University, Tainan, Taiwan 7 Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan 8 Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan * The authors contributed equally to this work Correspondence to: Ju-Ming Wang, email: yumingw@mail.ncku.edu.tw Keywords: HCC, autophagy, apoptosis, CEBPD, metformin Received: May 30, 2016 Accepted: January 04, 2017 Published: January 13, 2017 ABSTRACT Metformin, as an AMP-activated protein kinase (AMPK) activator, can activate autophagy. A study showed that metformin decreased the risk of hepatocellular carcinoma (HCC) in diabetic patients. However, the detailed mechanism in the metformin-mediated anticancer effect remains an open question. Transcription factor CCAAT/enhancer-binding protein delta (CEBPD) has been suggested to serve as a tumor suppressor and is responsive to multiple anticancer drugs in HCC. In this study, we found that CEBPD and autophagy are involved in metformin-induced cell apoptosis in Huh7 cells. The underlying mechanisms in this process included a reduction in Src-mediated CEBPD protein degradation and an increase in CEBPD-regulated LC3B and ATG3 gene transcription under metformin treatment. We also found that AMPK is involved in metformin-induced CEBPD expression. Combined treatment with metformin and rapamycin can enhance autophagic cell death through the AMPK-dependent and AMPK-independent pathway, respectively. Taken together, we provide a new insight and therapeutic approach by targeting autophagy in the treatment of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681 · cited 1×
“Many cancers develop resistance to chemotherapy drugs under single treatment, which is a major factor in the failure of many forms of chemotherapy [41].”
BackgroundMetformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Yeatman, T. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1366 · Cited by 1,113 · cited 1×
“The roles of Src in promoting tumor progression and metastasis have been well documented [35].”
BackgroundTFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop
Settembre, C., De Cegli, R., Mansueto, G., Saha, P. K., Vetrini, F., Visvikis, O., Huynh, T., Carissimo, A., Palmer, D., Jürgen Klisch, T., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2718 · Cited by 1,022
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Rouschop, K. M. A., van den Beucken, T., Dubois, L., Niessen, H., Bussink, J., Savelkouls, K., Keulers, T., Mujcic, H., Landuyt, W., Voncken, J. W., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40027 · Cited by 829
Shi, W.-Y., Xiao, D., Wang, L., Dong, L.-H., Yan, Z.-X., Shen, Z.-X., Chen, S.-J., Chen, Y., & Zhao, W.-L. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.13 · Cited by 308 · cited 2×
“Metformin is an AMPactivated protein kinase (AMPK) activator and can activate autophagy via a reduction in the mammalian target of rapamycin (mTOR) signaling pathway [11].”
BackgroundSelf-citationE2F1 regulates autophagy and the transcription of autophagy genes
Polager, S., Ofir, M., & Ginsberg, D. (2008) · Oncogene · doi:10.1038/onc.2008.117 · Cited by 260 · cited 3×
“In light of the recent findings on transcription factors EB (TFEB) [29], E2F1 [30], forkhead box O1 (FOXO1) [31], activating transcription factor 4 (ATF4) [32], CCAAT/enhancer-binding protein-β (C/EBPβ) [33] and C/EBPhomologous protein (CHOP) [34], we propose that a complex transcriptional network is involved in auto…”
BackgroundRapamycin: an anti-cancer immunosuppressant?
Law, B. K. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.009 · Cited by 252 · cited 1×
“Rapamycin, an mTOR inhibitor [26], has been suggested to serve an autophagy activator [27].”
BackgroundTemporal orchestration of circadian autophagy rhythm by C/EBPβ
Ma, D., Panda, S., & Lin, J. D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.322 · Cited by 234
The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia
Agrawal, S., Hofmann, W.-K., Tidow, N., Ehrich, M., Boom, D. V. D., Koschmieder, S., Berdel, W. E., Serve, H., & Müller-Tidow, C. (2007) · Blood · doi:10.1182/blood-2006-08-040147 · Cited by 119
Cited by
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Fujiwara, N., Friedman, S. L., Goossens, N., & Hoshida, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.016 · Cited by 659
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
“In fact, other salutary effects have been described for redox (Kocer et al., 2014; Kelleni et al., 2015) and protein homeostasis (Tsai et al., 2017).”
BackgroundKhandia, R., Dadar, M., Munjal, A., Dhama, K., Karthik, K., Tiwari, R., Yatoo, M. I., Iqbal, H. M. N., Singh, K. P., Joshi, S. K., et al. (2019) · Cells · doi:10.3390/cells8070674 · Cited by 314
Metadata
- Authors
- Tsai, H.-H., Lai, H.-Y., Chen, Y.-C., Li, C.-F., Huang, H.-S., Liu, H.-S., Tsai, Y.-S., & Wang, J.-M.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-01-13
- Volume
- 8
- Issue
- 8
- Pages
- 13832-13845
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2576839195
- Cited by
- 67
- References
- 12
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.